Find what you were looking for? Share your thoughts with a short survey

Our team

Our team helps coordinate and support activity across our partnership, working closely with colleagues in our partner organisations to drive delivery of our vision and mission.

Dr Stephen Thomas, Joint Director                                              

Stephen Thomas circleStephen is a clinical leader across diabetes, endocrinology and obesity at Guy’s and St Thomas’ NHS Foundation Trust (NHS FT) and has a strong understanding of the local system, having previously been a consultant at King’s College Hospital and an academic lecturer and academic research fellow in Diabetes & Endocrinology. 

Stephen’s clinical work focussed on looking after those with type 1 or type 2 diabetes who need extra specialist input and cares from people in internal medicine in an inpatient setting. Stephen is also a Clinical Director at the Trust and manages two busy directorates which focus on both outpatient and inpatient care, as well as a number of support functions.

Stephen is also the Clinical Director of the London Diabetes Clinical Network (NHS England, London Region), overseeing transformation and improvement across the capital to improve outcomes and reduce variation in care for people with diabetes. He was previously also the diabetes and long-term condition lead for Healthcare for London.

Dr Gavin Bewick, Joint Director

Gavin BewickGavin has a well-established reputation within the field of diabetes and obesity research built over the last 20 years and is an experienced leader within KCL. His current theme lead role focuses on research strategy within SCMMS, an area also identified as a priority for the DEO Clinical Academic Partnership. Gavin has also been a driving force behind the research and innovations workstream within DEO.

A key current interest of the Bewick lab is the role of the gut epithelium in the control of metabolism and the pathophysiology of diabetes and obesity. His lab is exploring the role of diet, the microbiome and immune signalling in shaping the gut epithelium in health and disease. The lab is also exploring how gut hormones can be targeted to prevent or treat Type 1 Diabetes. The lab used both pre-clinical and translational approaches encompassing methods ranging from organoid culture to single-cell transcriptomics to physiological studies.

Dr Sophie Harris, Joint Director 

Sophie HarrisSophie is a Diabetes Consultant and Clinical Lead for Diabetes at King’s College Hospital NHS FT, alongside her role as Deputy Clinical Director of Diabetes at the South London Health Innovation Network (HIN). Her role within the HIN gives her insight into current innovation and implementation priorities across South London. She has leadership roles within the NHSEI London clinical network for diabetes and has recently taken on national responsibilities, including chairing a Get It Right First Time (GIRFT) diabetes at the front door working group and leading a project for NHS England looking at user experience and outcomes in diabetes.

Her previous research investigated reasons for inequalities in uptake of self-management education in people with type 1 diabetes in South London. The findings of this PhD supported a successful application for NHS England transformation funding and the subsequent development and implementation of a diabetes booking platform across South London.

Sophie is a research active clinician with a strong understanding of the priorities within KCL, and a passion for addressing health inequalities in service access and delivery. Her specific interests are around digital health, improvement and implementation, self-care, patient education and empowerment, including peer- support strategies. With specific clinical interest in Type 1 diabetes, diabetes and eating disorders and diabetes in pregnancy.

Dr Shubulade (Lade) Smith, Joint Director

Lade SmithDr Lade Smith is a consultant psychiatrist and Clinical Director for the Forensic Service at the South London and Maudsley NHS FT. She is also a Visiting Senior Lecturer at the Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King’s College London and Clinical Director at the National Collaborating Centre for Mental Health (NCCMH).

She was awarded a CBE for services to forensic psychiatric intensive care in the Queen’s Birthday Honours 2019.She is Joint Presidential Lead for Race Equality at the Royal College of Psychiatrist. Alongside significant leadership experience, she has a strong academic focus and continues to do research at the IoPPN. She is also a clinical supervisor and trainer for junior psychiatrists from Guy's, King's, and St Thomas’ (GKT) Medical School, and teaches regularly on the DClinpsy and MRCPsych courses.

Shubulade was voted a BMA pioneering consultant and nominated as a Woman of the Year in 2002 for the development of her ‘One Stop Shop’, a medication review and physical monitoring clinic for people with mental health problems. She is known nationally and internationally for her work in the hormonal and reproductive effects of antipsychotic medications. Shubulade was responsible for some of the key sections in the influential ‘The Abandoned Illness’ report of the Schizophrenia Commission. More recently she was a key contributor to the Independent Mental Health Act Review, chaired by Professor Sir Simon Wessely. She led the Criminal Justice System topic group, and sat on the core working group, evidence review group and the African and Caribbean working group.

Ms Helen Kelsall, Joint Director

Helen KelsallHelen is Deputy Chief Nursing Officer at South London and the Maudsley NHS FT. She is also an active member of the research and development team at the Trust which works to ensure the co-ordination and delivery of several clinical research studies within the Trust, including clinical, academic, and commercial research.

Helen has worked across acute, mental health and community services, clinically and within leadership positions at NHS Foundation Trusts.  Prior to her current role, Helen was the Divisional Director of Nursing responsible for Acute and Emergency Medicine, Medical speciality Inpatient Services, Palliative care, and Cancer services, as well as a diverse number of Clinical Nurse Specialists, Advanced Nurse and Assistant Clinical Practitioners at Chelsea and Westminster NHS Foundation Trust.

She is currently responsible for the development and maintenance of professional standards across the Trust, contributing to strategic planning for the Trust as part of the Senior Nursing Leadership Team. Helen has experience in the delivery of both current and previous Trust’s strategic ambitions and quality priorities, including authoring and delivering Chelsea and Westminster 2020 – 2025 dementia clinical strategy. She co-led on the rapid redesign of non-elective patient pathways during the COVID-19 pandemic, having recognised a need for significant safe-service redesign. Helen leads on behalf of Nursing for the delivery of the South London and Maudsley NHS FT for Physical Health Care has a strong understanding of the local population but is also well connected with approaches to quality nationally.

Prof Emma Duncan, Joint Director

Emma DuncanEmma is a Professor of Clinical Endocrinology at King’s College London and Honorary Consultant Physician at Guy’s and St Thomas’s NHS FT. She is a specialist in endocrinology, with special interest in bone and neuroendocrine disease. She also holds roles as Professor of Medicine (honorary) at the University of Queensland and Adjunct Professor within the Faculty of Health at Queensland University of Technology. 

Emma is a highly experienced researcher and clinical research leader, who has led on both basic and clinical research studies across diverse areas of endocrinology. She has held many elected leadership positions within professional societies, contributing to leadership and governance nationally and internationally, previously serving as President of the Australian and New Zealand Bone and Mineral Society, and currently serving as Councillor for the American Society for Bone and Mineral Research and Associate Editor for the Journal for Bone and Mineral Research and Endocrine Reviews. 

Emma’s main area of work is Bone and skeletal dysplasias, and common and rare genetics. Her research spans the genetics of many endocrine disorders, from common variant to rare monogenic diseases, publishing multiple high-impact papers interrogating genetics of osteoporosis and skeletal dysplasias, MODY [maturity- onset diabetes of the young], and phaeochromocytomas and paragangliomas. Prof Duncan’s practical experience in gene mapping includes genetic epidemiology, linkage, genome-wide association studies, and massively parallel sequencing (MPS) technologies; and she has played a pioneering role in the translation of genetic technologies (such as high- throughput microarray genotyping and massively parallel sequencing) into clinical practice. Recently, she has contributed to COVID-19 research, particularly COVID-19 in children; and she co-leads the KCL COVID Symptom Study Biobank with particular focus on interrogating the genetics of the post-COVID syndrome. 

Hayley Ormandy, Programme Director

Hayley Ormandy headshot.jpgAs Programme Director for the KHP Diabetes, Endocrinology and Obesity Clinical Academic Partnership (KHP DEO), Hayley has responsibility for driving agreed strategic priorities and overseeing delivery of clinical academic transformation priorities that foster clinical, research, and education excellence for the benefit of our communities and partner organisations.

Hayley works in a joint role across South East London Integrated Care System as Programme Director for Vital 5 and Prevention. She is focused on supporting the development and delivery of an overarching Vital 5 implementation plan across south east London to ensure we maximise opportunities and impact, testing different models for preventative wellbeing services, and supporting the development of the SEL Integrated Care Partnership Prevention and Wellbeing Strategic Priority into action.

Prior to KHP - Hayley held senior level roles within NHS clinical commissioning, integrated care networks, and within a healthcare management consultancy.

Elana Covshoff, Senior Programme Manager 

Elana CovshoffElana joined King’s Health Partners Diabetes, Endocrinology & Obesity (KHP DEO) in March 2023. Elana Covshoff has worked in the healthcare sector for over a decade leading various STP/ICS-level clinical and workforce transformation programmes bringing meaningful change to patients and staff.

Elana’s key areas of expertise are developing and (re)designing clinical pathways and complex models of care to improve health outcomes. She developed from the ground up the SHRINE programme which is a KHP improvement programme delivering sexual and reproductive healthcare for people with severe addictions and/or serious mental illness. She also worked as a programme management consultant for Community Matters coordinating the North Central London Super Training Hub and managed the implementation of one of the first wave national pilot sites for the new Trainee Nursing Associate role funded by Health Education England. Elana’s years of experience developing integrated mind and body programmes provides her with the knowledge and skills to strengthen and expand the KHP Diabetes, Endocrinology and Obesity programme.

Elana loves learning and trying to understand about how the world works through history, geopolitics, health and international relations. Being the daughter of a librarian, she also enjoys reading.

Rosie Thistlethwayte, Programme Manager

Rosie ThistlethwayteRosie joined the KHP Diabetes, Endocrinology, and Obesity team in September 2022 as a programme manager. She is the team lead for diabetes and programme management lead for the One Team Clinical Transformation workstream. She also works on the integration of mental and physical health in the context of diabetes.

Prior to joining the team, Rosie completed the NHS Graduate Management Training Scheme, working as a service manager and then as project manager at Great Ormond Street Hospital NHS Foundation Trust , and as an executive officer at the Department of Health and Social Care. She has delivered a range of operational and strategic projects. These include the introduction of video appointments, the set-up of COVID-19 testing and vaccination clinics, and the introduction of a new paediatric complex obesity service.

She is a registered PRINCE2 Practitioner and has recently completed a masters in the Control of Infectious Diseases.

Isabel Rockingham, Programme Manager

Isabel DEOIsabel joined the KHP DEO team in November 2022 as a Programme Manager. She is the team lead for obesity and programme team lead for the One Team Education and Training workstream. She also contributes to the KHP work on Population Health from an obesity perspective. 

Before joining KHP, Isabel completed the NHS Graduate Management Training Scheme (GMTS) and held multiple operational and strategic roles in a range of settings. She has experience of primary care commissioning at place and national levels and has led on projects relating to health inequalities, COVID-19 vaccinations, and remote monitoring. At system level, Isabel worked as an Integrated Care System Programme Development Manager, overseeing the successful merging of three Clinical Commissioning Groups into an Integrated Care Board, and producing an organisational strategy for engaging with people and communities. 

Isabel also contributed to quality improvement projects during her time in a Big four consulting firm and led transformation initiatives alongside her operational management responsibilities as Service Support Manager at Oxford University Hospitals NHS Foundation Trust.

Evegnia Kovryga (Education & Training Project Support Officer - Interim)

Evegnia KovrygaEvgenia initially joined KHP Women and Children’s Health in November 2021 as maternity cover to support and facilitate Education and Training programmes. Since January 2022 she has also joined KHP DEO assisting the team with One Team Education & Training priority areas. Evgenia’s professional experience sits predominantly in Higher Education with various responsibilities across Academic Development and Services, Admissions, PG, PhD and Research Support and Quality Assurance.  As a recent MA Advance Theatre Practice graduate, Evgenia also brings a creative background and experience in production to DEO.

To get in touch with the Institute and learn more about our work, please email